U.S. Markets open in 6 hrs 43 mins

Oramed in talks with big pharma on oral insulin product, Bloomberg says

Oramed may partner with Novo Nordisk or others, says Bloomberg. Oramed expects results of Phase ll FDA trial by year-end, added Bloomberg.